Literature DB >> 6802523

Detection of the Sanfilippo type B syndrome using radiolabelled oligosaccharides as substrates for the estimation of alpha-N-acetylglucosaminidase.

J J Hopwood, H Elliott.   

Abstract

1. The following radiolabelled disaccharides were prepared from heparin and evaluated as substrates for alpha-N-acetylglucosaminidase present in cultured skin fibroblasts: O-(alpha-3-acetamido-2-deoxy-D-glucopyranosyl)-(1 leads to 4)-L-[6,3H]idose (GlcNAc-Ido), O-(alpha-2-acetamido-2-deoxy-D-glucopyranosyl)-(1 leads to 4)-1,6 anhydro-L-[6,3H]idose (GlcNAc-anIdo), O-(alpha-2-acetamido-2-deoxy-D-glucopyranosyl)-(1 leads to 4)-L-[6,3H]idose 2-sulfate (GlcNAc-Ido(OS)), O-(alpha 2-acetamido-2-deoxy-D-glucopyranosyl)-(1 leads to 3)-L-[6,3H]idonic acid (GlcNAc-IdOA). 2. Alpha-N-Acetylglucosaminidase activity assessed with GlcNAc-IdOA was 12 times higher than the values obtained using GlcNAc-Ido, GlcNAc-anIdo and GlcNAc-Ido(OS). Less than 5% of normal activity resulted when these substrates were incubated with fibroblasts from Sanfilippo B patients. These results demonstrate that a C6 carboxyl group on the adjacent residue to the N-acetylglucosaminide moiety is an important structural requirement in the mechanism of action or binding of alpha-N-acetylglucosaminidase toward alpha-linked N-acetylglucosaminide residues. The presence of a C2 sulfate group on the adjacent residue had no effect on enzyme activity. 3. Alpha-N-Acetylglucosaminidase activity in leucocyte and fibroblast homogenates assayed using GlcNAc-IdOA as substrate clearly distinguished Sanfilippo B patients from normal controls, and Sanfilippo A, C and D patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6802523     DOI: 10.1016/0009-8981(82)90079-1

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  10 in total

1.  A rapid quantitative assay for the detection of mammalian heparanase activity.

Authors:  C Freeman; C R Parish
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

2.  New substrates and enzyme assays for the detection of mucopolysaccharidosis III (Sanfilippo Syndrome) types A, B, C, and D by tandem mass spectrometry.

Authors:  Brian J Wolfe; Farideh Ghomashchi; Tim Kim; Cynthia A Abam; Martin Sadilek; Rhona Jack; Jerry N Thompson; C Ronald Scott; Michael H Gelb; Frantisek Turecek
Journal:  Bioconjug Chem       Date:  2012-03-09       Impact factor: 4.774

3.  Glycoside hydrolase family 89 alpha-N-acetylglucosaminidase from Clostridium perfringens specifically acts on GlcNAc alpha1,4Gal beta1R at the non-reducing terminus of O-glycans in gastric mucin.

Authors:  Masaya Fujita; Akiko Tsuchida; Akiko Hirata; Natsumi Kobayashi; Kohtaro Goto; Kenji Osumi; Yuriko Hirose; Jun Nakayama; Takashi Yamanoi; Hisashi Ashida; Mamoru Mizuno
Journal:  J Biol Chem       Date:  2010-12-21       Impact factor: 5.157

4.  Human glucosamine-6-sulphatase deficiency. Diagnostic enzymology towards heparin-derived trisaccharide substrates.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

5.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

6.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization.

Authors:  C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

7.  Bovine mucopolysaccharidosis type IIIB.

Authors:  L Karageorgos; B Hill; M J Bawden; J J Hopwood
Journal:  J Inherit Metab Dis       Date:  2007-04-24       Impact factor: 4.982

8.  Human liver glucuronate 2-sulphatase. Purification, characterization and catalytic properties.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1989-04-01       Impact factor: 3.857

9.  A rapid and sensitive method for measuring N-acetylglucosaminidase activity in cultured cells.

Authors:  Victor Mauri; Parisa Lotfi; Laura Segatori; Marco Sardiello
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

Review 10.  Sanfilippo syndrome: causes, consequences, and treatments.

Authors:  Anthony O Fedele
Journal:  Appl Clin Genet       Date:  2015-11-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.